Vince Kornél Grolmusz

5PUBLICATIONS
9CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene expression (incl. microarray and other genome-wide approaches)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 27, 2026
A novel combination therapy for ER+ breast cancer suppresses drug resistance via an evolutionary double-bind.

Rena Emond, Jeffrey West, Vince K Grolmusz

|May 09, 2025
Blocking cancer-fibroblast mutualism inhibits proliferation of endocrine therapy resistant breast cancer.

Jason I Griffiths, Feng Chi, Elena Farmaki

|Jan 18, 2025
Whole genome sequencing completes the molecular genetic testing workflow of patients with Lynch syndrome.

Klaudia Horti-Oravecz, Anikó Bozsik, Tímea Pócza

|Jun 23, 2020
Exploiting collateral sensitivity controls growth of mixed culture of sensitive and resistant cells and decreases selection for resistant cells in a cell line model.

Vince Kornél Grolmusz, Jinfeng Chen, Rena Emond

|Jun 10, 2017
MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism.

Vince Kornél Grolmusz, Katalin Borka, Annamária Kövesdi

Pageof 1

Frequent Collaborators

2 joint publications

Patrick A Cosgrove

2 joint publications

Andrea H Bild

1 joint publications

Jason I Griffiths

1 joint publications

Kimya L Karimi